Bimekizumab superior to ustekinumab for plaque psoriasis
(HealthDay)—For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. 6 issue of The Lancet.
Feb 5, 2021
0
2
